Debolosan, Lida D.
HRN: 24-09-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/14/2023
CEFUROXIME 1.5GM (VIAL)
11/14/2023
11/20/2023
IV
1.5gm
Q8
Cap Mr
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes